These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 8810132

  • 1. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
    Ikeda H, Kihira K, Kuwata N, Arai S, Kimura Y, Miyake K, Kitaura T, Fujimura K, Kuramoto A, Fukuchi H.
    Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
    Niemann A, Mühlisch J, Frühwald MC, Gerss J, Hempel G, Boos J.
    Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P, Oviedo I, Campbell M, Tordecilla J.
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Severe renal impairment of methotrexate elimination after high dose therapy].
    Lawrenz-Wolf B, Wolfrom C, Frickel C, Fengler R, Wehinger H, Henze G.
    Klin Padiatr; 1994 Jul; 206(4):319-26. PubMed ID: 7967432
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma].
    Fernández Megía MJ, Alós Almiñana M, Esquer Borrás J.
    Farm Hosp; 2004 Jul; 28(6):433-9. PubMed ID: 15628946
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC.
    Cancer; 2004 Apr 15; 100(8):1724-33. PubMed ID: 15073863
    [Abstract] [Full Text] [Related]

  • 11. Fever as a risk factor causing delayed elimination of methotrexate in pediatric patients receiving high doses of cancer chemotherapy.
    Kagawa Y, Mukohara R, Hori H, Kawasaki H, Komada Y, Kojima M.
    Cancer Chemother Pharmacol; 2004 Jul 15; 54(1):34-8. PubMed ID: 15024606
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prolonged accumulation of high-dose methotrexate in a case with large liver cysts.
    Kawakami M, Omori H, Yamagami T, Soma T.
    Cancer Chemother Pharmacol; 2009 Aug 15; 64(3):619-22. PubMed ID: 19319534
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma.
    Gerber DE, Grossman SA, Batchelor T, Ye X.
    Cancer Chemother Pharmacol; 2007 May 15; 59(6):817-23. PubMed ID: 16972068
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Investigation on individualized adjustment of target range of high-dose methotrexate].
    Hua Y, Zhao WH, Lu XT, Yang LH, Lu W.
    Zhonghua Er Ke Za Zhi; 2008 Mar 15; 46(3):203-8. PubMed ID: 19099710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.